CDC42BPA and skin neoplasm: An antibody against the phosphorylated MRCKα Ser1003 revealed elevated levels of active kinase in genetic and chemically-induced mouse skin tumours, and also provided evidence that topical application of a selective MRCK small molecule inhibitor successfully blocked kinase activity [11].